| D-0384-2026 — Rising Pharma Holding, Inc. | Class II | Mar 3, 2026 |
| D-0390-2026 — STRIDES PHARMA INC | Class II | Mar 2, 2026 |
| D-0403-2026 — MACLEODS PHARMA USA, INC | Class II | Feb 26, 2026 |
| D-0394-2026 — New Life Pharma LLC | Class II | Feb 26, 2026 |
| D-0393-2026 — New Life Pharma LLC | Class II | Feb 26, 2026 |
| D-0395-2026 — New Life Pharma LLC | Class II | Feb 26, 2026 |
| D-0392-2026 — New Life Pharma LLC | Class II | Feb 26, 2026 |
| D-0382-2026 — Cipla USA, Inc. | Class III | Feb 18, 2026 |
| D-0381-2026 — Cipla USA, Inc. | Class III | Feb 18, 2026 |
| H-0689-2026 — SUNGAL INC | Class II | Feb 12, 2026 |
| D-0339-2026 — LEO PHARMA INC | Class II | Feb 10, 2026 |
| Z-1574-2026 — LeMaitre Vascular, Inc. | Class II | Feb 10, 2026 |
| Z-1587-2026 — Datascope Corp. | Class III | Feb 6, 2026 |
| Z-1585-2026 — Diagnostica Stago, Inc. | Class II | Feb 5, 2026 |
| Z-1491-2026 — Diagnostica Stago, Inc. | Class II | Feb 4, 2026 |
| D-0398-2026 — SOMERSET THERAPEUTICS LLC | Class II | Feb 4, 2026 |
| Z-1572-2026 — Howmedica Osteonics Corp. | Class II | Feb 2, 2026 |
| D-0355-2026 — Teva Pharmaceuticals USA, Inc | Class II | Jan 29, 2026 |
| D-0354-2026 — Teva Pharmaceuticals USA, Inc | Class II | Jan 29, 2026 |
| D-0357-2026 — Teva Pharmaceuticals USA, Inc | Class II | Jan 29, 2026 |
| D-0356-2026 — Teva Pharmaceuticals USA, Inc | Class II | Jan 29, 2026 |
| Z-1496-2026 — Becton Dickinson & Company | Class II | Jan 27, 2026 |
| D-0342-2026 — SUN PHARMACEUTICAL INDUSTRIES INC | Class II | Jan 27, 2026 |
| Z-1487-2026 — Datascope Corp. | Class II | Jan 23, 2026 |
| Z-1486-2026 — Datascope Corp. | Class II | Jan 23, 2026 |
| D-0306-2026 — Unichem Pharmaceuticals USA Inc. | Class III | Jan 21, 2026 |
| D-0301-2026 — Unichem Pharmaceuticals USA Inc. | Class II | Jan 21, 2026 |
| Z-1363-2026 — Integra LifeSciences Corp. (NeuroSciences) | Class II | Jan 16, 2026 |
| Z-1364-2026 — Integra LifeSciences Corp. (NeuroSciences) | Class II | Jan 16, 2026 |
| H-0570-2026 — Dr. Praeger's Sensible Foods Inc. | Class II | Jan 16, 2026 |
| Z-1365-2026 — Integra LifeSciences Corp. (NeuroSciences) | Class II | Jan 16, 2026 |
| D-0299-2026 — Greenstone Llc | Class II | Jan 15, 2026 |
| D-0445-2026 — Teva Pharmaceuticals USA, Inc | Class II | Jan 12, 2026 |
| D-0446-2026 — Teva Pharmaceuticals USA, Inc | Class II | Jan 12, 2026 |
| D-0290-2026 — Cipla USA, Inc. | Class II | Jan 2, 2026 |
| D-0259-2026 — Alvogen, Inc | Class II | Dec 31, 2025 |
| D-0256-2026 — SUN PHARMACEUTICAL INDUSTRIES INC | Class III | Dec 30, 2025 |
| D-0295-2026 — Zydus Pharmaceuticals (USA) Inc | Class II | Dec 30, 2025 |
| D-0246-2026 — Glenmark Pharmaceuticals Inc., USA | Class II | Dec 30, 2025 |
| H-0667-2026 — Mondelez Global Llc | Class II | Dec 30, 2025 |
| D-0297-2026 — Haleon US Holdings LLC | Class III | Dec 26, 2025 |
| D-0332-2026 — HANDELNINE GLOBAL LLC | Class I | Dec 22, 2025 |
| D-0291-2026 — Cipla USA, Inc. | Class III | Dec 22, 2025 |
| D-0247-2026 — Zydus Pharmaceuticals (USA) Inc | Class III | Dec 19, 2025 |
| D-0245-2026 — Novo Nordisk Inc. | Class II | Dec 19, 2025 |
| D-0244-2026 — Novo Nordisk Inc. | Class II | Dec 19, 2025 |
| D-0251-2026 — Imprimis NJOF, LLC | Class II | Dec 18, 2025 |
| D-0250-2026 — Imprimis NJOF, LLC | Class II | Dec 18, 2025 |
| D-0249-2026 — Imprimis NJOF, LLC | Class II | Dec 18, 2025 |
| H-0418-2026 — QUTEN RESEARCH INSTITIUTE LLC | Class II | Dec 16, 2025 |